BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 22867045)

  • 21. Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update.
    Morgan DJ; McLean AJ
    Clin Pharmacokinet; 1995 Nov; 29(5):370-91. PubMed ID: 8582120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No influence of mild-to-moderate hepatic impairment on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor.
    Wåhlander K; Eriksson-Lepkowska M; Frison L; Fager G; Eriksson UG
    Clin Pharmacokinet; 2003; 42(8):755-64. PubMed ID: 12846596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacology of tramadol].
    Dayer P; Desmeules J; Collart L
    Drugs; 1997; 53 Suppl 2():18-24. PubMed ID: 9190321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management.
    Gillis JC; Brogden RN
    Drugs; 1997 Jan; 53(1):139-88. PubMed ID: 9010653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analgesia for the cirrhotic patient: a literature review and recommendations.
    Dwyer JP; Jayasekera C; Nicoll A
    J Gastroenterol Hepatol; 2014; 29(7):1356-60. PubMed ID: 24548074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of liver and renal dysfunction on the pharmacokinetics of sedatives and analgesics in the critically ill patient.
    Yogaratnam D; Miller MA; Smith BS
    Crit Care Nurs Clin North Am; 2005 Sep; 17(3):245-50. PubMed ID: 16115532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous assessment of drug interactions with low- and high-extraction opioids: application to parecoxib effects on the pharmacokinetics and pharmacodynamics of fentanyl and alfentanil.
    Ibrahim AE; Feldman J; Karim A; Kharasch ED
    Anesthesiology; 2003 Apr; 98(4):853-61. PubMed ID: 12657846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tramadol with or without paracetamol (acetaminophen) for cancer pain.
    Wiffen PJ; Derry S; Moore RA
    Cochrane Database Syst Rev; 2017 May; 5(5):CD012508. PubMed ID: 28510996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analgesia in patients with hepatic impairment].
    Innaurato G; Piguet V; Simonet ML
    Rev Med Suisse; 2015 Jun; 11(480):1380, 1382-4. PubMed ID: 26267943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pain control after liver transplantation surgery.
    Feltracco P; Carollo C; Barbieri S; Milevoj M; Pettenuzzo T; Gringeri E; Boetto R; Ori C
    Transplant Proc; 2014 Sep; 46(7):2300-7. PubMed ID: 25242774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update.
    Scholz J; Steinfath M; Schulz M
    Clin Pharmacokinet; 1996 Oct; 31(4):275-92. PubMed ID: 8896944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered Pharmacokinetics in Prolonged Infusions of Sedatives and Analgesics Among Adult Critically Ill Patients: A Systematic Review.
    Tse AHW; Ling L; Lee A; Joynt GM
    Clin Ther; 2018 Sep; 40(9):1598-1615.e2. PubMed ID: 30173953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic changes of tramadol in rats with hepatotoxicity induced by ethanol and acetaminophen in perfused rat liver model.
    Mohammadi S; Nezami A; Esmaeili Z; Rouini MR; Ardakani YH; Lavasani H; Hassanzadeh G; Ghazi-Khansari M
    Alcohol; 2019 Jun; 77():49-57. PubMed ID: 30248395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenetics of analgesics: toward the individualization of prescription.
    Rollason V; Samer C; Piguet V; Dayer P; Desmeules J
    Pharmacogenomics; 2008 Jul; 9(7):905-33. PubMed ID: 18597654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pharmacology of tramadol.
    Grond S; Sablotzki A
    Clin Pharmacokinet; 2004; 43(13):879-923. PubMed ID: 15509185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiarrhythmics: elimination and dosage considerations in hepatic impairment.
    Klotz U
    Clin Pharmacokinet; 2007; 46(12):985-96. PubMed ID: 18027986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug administration in chronic liver disease.
    Westphal JF; Brogard JM
    Drug Saf; 1997 Jul; 17(1):47-73. PubMed ID: 9258630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of opioids in renal dysfunction.
    Davies G; Kingswood C; Street M
    Clin Pharmacokinet; 1996 Dec; 31(6):410-22. PubMed ID: 8968655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Is remifentanil an ideal opioid for anesthesiologic management in the 21st century?].
    Scholz J; Steinfath M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Dec; 31(10):592-607. PubMed ID: 9081416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demographics, assessment and management of pain in the elderly.
    Davis MP; Srivastava M
    Drugs Aging; 2003; 20(1):23-57. PubMed ID: 12513114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.